Rheumatology
News
Drugs
Xagena Medicine
Xagena.net
Psoriatic arthritis: significant and sustained improvements with Golimumab
Decreased risk of developing rheumatoid arthritis linked to alcohol intake
Treatment of Denosumab reduces the progression of bone erosion
B-cell depletion therapy for patients with refractory systemic lupus erythematosus
Belimumab improves symptoms in 46 percent of systemic lupus erythematosus patients
Exercise has no effect on risk of knee osteoarthritis
Predicting the risk of rheumatoid arthritis for early arthritis patients
Spondylarthritis: the process of ankylosis could become a separate therapeutic target
Low-dose steroids reduce joint damage from rheumatoid arthritis
Inflammatory arthritis: changes in serum fetal DNA levels associated with disease improvement during pregnancy and recurrence postpartum
Efficacy of Glucosamine, Chondroitin sulfate in patients with moderate to severe osteoarthritis knee pain
Rheumatoid arthritis: chronic, severe inflammation linked to increased lymphoma risk
Acupuncture relieves symptoms of fibromyalgia
Rheumatoid arthritis does not increase risk of hearing loss
FDA has approved Rituxan for treatment of moderate-to-severe rheumatoid arthritis
Statins as potential modifiers of rheumatoid arthritis
The impact of smoking and genes on rheumatoid arthritis
Combination therapy, Adalimumab plus Methotrexate, for achieving remission of early rheumatoid arthritis
Valproic acid, a common anti-seizure drug, could be effective for lupus
Rheumatoid arthritis: Etanercept and Methotrexate combination has demonstrated improvement in physical function and kept joint damage from progressing
Resetting epigenetic code could aid patients with systemic lupus erythematosus
Yoga is more effective than conventional exercise for back pain
Rheumatoid arthritis: PTPN22 1858T polymorphism and anti-CCP antibodies linked to increased risk
Safety of oral contraceptives in women with lupus erythematosus
Regular physical activity may strenghten knee cartilage
dnaJP1 appears effective for rheumatoid arthritis
The role of Type II Collagen in rheumatoid arthritis
Rheumatic disease increases risks in pregnancy
Rheumatoid arthritis, cannabis-based medicine relieves the pain and suppresses the disease
FDA approves Humira for first-line treatment of moderate to severe rheumatoid arthritis
Next Pages [
1
]
2
Web
Xagena News
Link
•
Allergology
•
Andrology
•
Biomedicine
•
Cardiology
•
Dermatology
•
Diabetology
•
Diagnostics
•
Drugs
•
Endocrinology
•
Gastroenterology
•
Gene Medicine
•
Gynecology
•
Hematology
•
Hepatology
•
Infectivology
•
Metabolism
•
Nephrology
•
Neurology
•
Oncology
•
Ophthalmology
•
Pediatrics
•
Pharmacology
•
Pneumology
•
Psychiatry
•
Rheumatology
•
Stem Therapy
•
Urology
•
Vaccines
•
Virology
n
Xagena.it
Powered by Luca Malattia -
LM Web Solutions